Dr. Xiaofeng Meng is currently serving as the President of The WhiteOak Consulting with offices located at Hangzhou, China and Marylan, USA. Graduated with Ph.D/MBA Degree from Rutgers, the State University of New Jersey and Master Degree from Shanghai Institute of Pharmaceutical Industry, Dr. Meng owns more than 20-year experience in pharmaceutical industry and is well recognized as the expert in global regulatory affair and quality management.
At different positions, Dr. Meng has been working on various IND, NDA, ANDA and MA submission with FDA, EMA and China NMPA, covering oral solid, injectables, inhalation, nasal spray and other dosage forms. At The WhiteOak Consulting, Dr. Meng and his team has supported many US and China major pharmaceutical companies for their global regulatory submission, GMP system establishment and official regulatory inspection. In addition, Dr. Meng has extensive experience in product launch of OTC, Rx generic and branded product to global market.